DU

DuChemBio Co, LTD

Develops & commercializes PET/CT tracers for diagnosing cancer & neurological disorders.

176750 | KO

Overview

Corporate Details

ISIN(s):
KR7176750008
LEI:
Country:
South Korea
Address:
서울특별시 마포구 와우산로 81(서교동, 서봉갤러리), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

DuChemBio Co., Ltd. is a radiopharmaceutical company specializing in the development, manufacturing, and commercialization of products for nuclear medicine. The company focuses on producing innovative tracers for Positron Emission Tomography (PET/CT) scans, primarily used for the diagnosis and treatment of cancer and neurological disorders like Parkinson's disease. Operating a fully integrated business model, DuChemBio manages the entire value chain from research and development to production in its GMP-compliant facilities and sales. Its mission is to develop novel diagnostic and therapeutic agents and achieve successful commercialization both domestically and globally. The company also imports and distributes related medical equipment.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB
2025-08-18 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.4 MB
2025-08-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-06-02 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-05-21 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-05-13 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.8 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 23.4 KB
2025-03-31 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 10.3 KB
2025-03-31 00:00
Post-Annual General Meeting Information
상호변경안내
Korean 5.4 KB
2025-03-31 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 14.9 KB
2025-03-21 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-21 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 469.0 KB
2025-03-17 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집공고
Korean 962.1 KB

Automate Your Workflow. Get a real-time feed of all DuChemBio Co, LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for DuChemBio Co, LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for DuChemBio Co, LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BOIRON Logo
Global manufacturer of homeopathic medicines for pain relief and flu-like symptoms, sold worldwide.
France
BOI
Bon Natural Life Ltd Logo
Bio-manufactures natural plant ingredients for fragrances, supplements, and immunity solutions.
United States of America
BON
Bosnalijek d.d. Sarajevo Logo
Global manufacturer of drugs for digestive, metabolic, and cardiovascular health.
Bosnia and Herzegovina
BSNL
Boundless Bio, Inc. Logo
Developing ecDNA-directed therapies for intractable oncogene amplified cancers.
United States of America
BOLD
BridgeBio Oncology Therapeutics, Inc. Logo
Clinical-stage biopharma creating small molecule drugs for RAS-dependent cancers.
United States of America
BBOT
BridgeBio Pharma, Inc. Logo
Develops transformative medicines for genetic diseases and genetically driven cancers.
United States of America
BBIO
BRIGHT MINDS BIOSCIENCES INC. Logo
Developing next-gen serotonergic drugs for neurological and psychiatric disorders like epilepsy.
United States of America
DRUG
BRISTOL MYERS SQUIBB CO Logo
Develops innovative medicines for oncology, immunology, and cardiovascular diseases.
United States of America
BMY
R&D pharma firm developing drugs for CNS disorders, oncology, and metabolic diseases.
South Korea
003000
Burning Rock Biotech Ltd Logo
Offers NGS-based diagnostics for precision oncology, from detection to clinical trial support.
United States of America
BNR

Talk to a Data Expert

Have a question? We'll get back to you promptly.